NextCure, Inc. (NXTC) has 8 open-market insider trades by 6 insiders since 2019. Over the last six months insiders net bought $1.4M. The most active filer is Sofinnova Venture Partners IX, L.P., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sofinnova Venture Partners IX, L.P. via James Healy | 10% Owner | — | 2 | $11.5M | 2019-11-15 |
| Chau Quang Khuong | Dir | — | 1 | $5.3M | 2019-05-13 |
| Stella Xu | Dir | — | 1 | $1.9M | 2019-05-13 |
| ADAR1 Capital Management, LLC | 10% Owner | — | 2 | $1.6M | 2026-07-31 |
| Timothy M. Shannon | Dir | — | 1 | $750K | 2019-05-13 |
| Simcere Zaiming, Inc. | — | — | 1 | $185K | 2026-08-10 |
| OrbiMed Capital GP VI LLC | Dir10% Owner | — | 0 | — | 2019-05-13 |
| Canaan X L.P. | 10% Owner | — | 0 | — | 2019-05-13 |
| Sofinnova Management IX, L.L.C. | 10% Owner | — | 0 | — | 2019-05-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Simcere Zaiming, Inc. | — | Sell | $185K | 2026-08-10 |
| ADAR1 Capital Management, LLC | 10% Owner | Buy | $1.5M | 2026-07-30 |
| ADAR1 Capital Management, LLC | 10% Owner | Buy | $88K | 2026-07-27 |
| Sofinnova Venture Partners IX, L.P. | 10% Owner | Buy | $5.5M | 2019-11-15 |
| Sofinnova Venture Partners IX, L.P. | 10% Owner | Buy | $6.0M | 2019-05-13 |
| Chau Quang Khuong | Director | Buy | $5.3M |
Companies that share insiders with NXTC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-05-13 |
| Stella Xu | Director | Buy | $1.9M | 2019-05-13 |
| Timothy M. Shannon | Director | Buy | $750K | 2019-05-13 |